Bruker (BRKR) said Wednesday it has acquired a majority interest in RECIPE Chemicals + Instruments, a Munich-based provider of therapeutic drug monitoring and other clinical in vitro diagnostic kits.
Financial terms of the transaction were not disclosed.
Bruker said the deal enhances its small molecule clinical diagnostics portfolio by integrating RECIPE's ClinMASS kits with its EVOQ liquid chromatography triple-quadrupole mass spectrometers and other platforms.
The companies also plan to jointly launch chromatography-free ClinDART kits.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.